Association between dopamine beta hydroxylase rs5320 polymorphism and smoking behaviour in elderly Japanese

Journal of Human Genetics

Volumn 57, Issue 6, 2012, Pages 385-390

  Ella, Elakeche ^a,b   Sato, Naomi ^b   Nishizawa, Daisuke ^c   Kageyama, Shinji ^b   Yamada, Hidetaka ^a   Kurabe, Nobuya ^b   Ishino, Keiko ^b   Tao, Hong ^b   Tanioka, Fumihiko ^d   Nozawa, Akiko ^b   Renyin, Chen ^b,e   Shinmura, Kazuya ^b   Ikeda, Kazutaka ^c   Sugimura, Haruhiko ^b  

^a UNIVERSITY OF MALTA MEDICAL SCHOOL   (Malta)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d Iwata City Hospital   (Japan)

^e ZHENGZHOU UNIVERSITY   (China)

Author keywords

addiction; dopamine beta hydroxylase (DBH); Fagerstr m Test for Nicotine Dependence (FTND); nicotine dependence; single nucleotide polymorphism (SNP); smoking behaviour; Tobacco Dependence Screener (TDS)

Indexed keywords

DOPAMINE BETA MONOOXYGENASE;

ADULT; AGED; BLOOD SAMPLING; FEMALE; GENE FREQUENCY; GENOTYPE; GERIATRIC PATIENT; HUMAN; JAPANESE; LIFESTYLE; LUNG CANCER; MALE; QUESTIONNAIRE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TOBACCO DEPENDENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; DOPAMINE BETA-HYDROXYLASE; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; TOBACCO USE DISORDER;

NICOTIANA TABACUM;

EID: 84862840272     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2012.40     Document Type: Review

References (36)

1. Stewart, L. C. & Klinman, J. P. Dopamine beta-hydroxylase of adrenal chromaffin granules: structure and function. Annu. Rev. Biochem. 57, 551-592 (1988).
2. Weinshilboum, R. M., Thoa, N. B., Johnson, D. G., Kopin, I. J. & Axelrod, J. Proportional release of norepinephrine and dopamine-hydroxylase from sympathetic nerves. Science 174, 1349-1351 (1971).
3. Smith, A. D., De Potter, W. P., Moerman, E. J. & De Schaepdryver, A. F. Release of dopamine beta-hydroxylase and chromogranin A upon stimulation of the splenic nerve. Ti s s u e C e l l 2, 547-568 (1970).
4. Craig, S. P., Buckle, V. J., Lamouroux, A., Mallet, J. & Craig, I. W. Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenet. Cell Genet. 48, 48-50 (1988). (Pubitemid 18265296)
5. 0-terminal regions are produced through alternative polyadenylation. Nucleic Acids Res. 17, 1089-1102 (1989). (Pubitemid 19062891)
6. Dunnette, J. & Weinshilboum, R. Human serum dopamine beta-hydroxylase: correlation of enzymatic activity with immunoreactive protein in genetically defined samples. Am. J. Hum. Genet. 28, 155-166 (1976).
7. Dunnette, J. & Weinshilboum, R. Inheritance of low immunoreactive human plasma dopamine-beta-hydroxylase. Radioimmunoassay studies. J. Clin. Invest. 60, 1080-1087 (1977). (Pubitemid 8223134)
8. Dunnette, J. & Weinshilboum, R. Family studies of plasma dopamine-beta-hydroxylase thermal stability. Am. J. Hum. Genet. 34, 84-99 (1982). (Pubitemid 12173642)
9. Dunnette, J. H. & Weinshilboum, R. M. Serum dopamine beta-hydroxylase activity in non-human primates: phylogenetic and genetic implications. Comp. Biochem. Physiol. C. 75, 85-91 (1983). (Pubitemid 13037165)
10. Cubells, J. F. & Zabetian, C. P. Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology (Berl) 174, 463-476 (2004). (Pubitemid 39119336)
11. Kim, C. H., Zabetian, C. P., Cubells, J. F., Cho, S., Biaggioni, I., Cohen, B. M. et al. Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency. Am. J. Med. Genet. 108, 140-147 (2002).
12. Timmers, H. J., Deinum, J., Wevers, R. A. & Lenders, J. W. Congenital dopamine-beta-hydroxylase deficiency in humans. Ann. N.Y. Acad. Sci. 1018, 520-523 (2004).
13. Punia, S., Das, M., Behari, M., Mishra, B. K., Sahani, A. K., Govindappa, S. T. et al. Role of polymorphisms in dopamine synthesis and metabolism genes and association of DBH haplotypes with Parkinson's disease among North Indians. Pharmacogenet. Genomics 20, 435-441 (2010).
14. Sato, N., Kageyama, S., Chen, R., Suzuki, M., Mori, H., Tanioka, F. et al. Association between neuropeptide Y receptor 2 polymorphism and the smoking behavior of elderly Japanese. J. Hum. Genet. 55, 755-760 (2010).
15. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C. & Fagerstrom, K. O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 86, 1119-1127 (1991).
16. Kawakami, N., Takatsuka, N., Inaba, S. & Shimizu, H. Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. Addict. Behav. 24, 155-166 (1999). (Pubitemid 29147114)
17. Sato, N., Kageyama, S., Chen, R., Suzuki, M., Tanioka, F., Kamo, T. et al. Association between neurexin 1 (NRXN1) polymorphisms and the smoking behavior of elderly Japanese. Psychiatr. Genet. 20, 135-136 (2010).
18. Ghosh, J., Pradhan, S. & Mittal, B. Role of dopaminergic gene polymorphisms (DBH 19 bp Indel and DRD2 Nco I) in genetic susceptibility to migraine in North Indian population. Pain Med. 12, 1109-1111 (2011).
19. Bhaduri, N., Sarkar, K., Sinha, S., Chattopadhyay, A. & Mukhopadhyay, K. Study on DBH genetic polymorphisms and plasma activity in attention deficit hyperactivity disorder patients from Eastern India. Cell Mol. Neurobiol. 30, 265-274 (2009).
20. Chen, Y., Wen, G., Rao, F., Zhang, K., Wang, L., Rodriguez-Flores, J. L. et al. Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure. J. Hypertens. 28, 76-86 (2010).
21. Brousse, G., Vorspan, F., Ksouda, K., Bloch, V., Peoc'h, K., Laplanche, J. L. et al. Could the inter-individual variability in cocaine-induced psychotic effects influence the development of cocaine addiction? Towards a new pharmacogenetic approach to addictions. Med. Hypotheses 75, 600-604 (2010).
22. Combarros, O., Warden, D. R., Hammond, N., Cortina-Borja, M., Belbin, O., Lehmann, M. G. et al. The dopamine beta-hydroxylase-1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project. BMC Med. Genet. 11, 162 (2010).
23. Zabetian, C. P., Anderson, G. M., Buxbaum, S. G., Elston, R. C., Ichinose, H., Nagatsu, T. et al. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am. J. Hum. Genet. 68, 515-522 (2001). (Pubitemid 32147822)
24. Freire, M. T., Marques, F. Z., Hutz, M. H. & Bau, C. H. Polymorphisms in the DBH and DRD2 gene regions and smoking behavior. Eur. Arch. Psychiatry Clin. Neurosci. 256, 93-97 (2006).
25. McKinney, E. F., Walton, R. T., Yudkin, P., Fuller, A., Haldar, N. A., Mant, D. et al. Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics 10, 483-491 (2000).
26. The Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 42, 441-447 (2010).
27. Siedlinski, M., Cho, M. H., Bakke, P., Gulsvik, A., Lomas, D. A., Anderson, W. et al. Genome-wide association study of smoking behaviours in patients with COPD. Thorax 66, 894-902 (2011).
28. Huang, S., Cook, D. G., Hinks, L. J., Chen, X. H., Ye, S., Gilg, J. A. et al. CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents. Pharmacogenet. Genomics 15, 839-850 (2005). (Pubitemid 41666766)
29. Breitling, L. P., Twardella, D., Hoffmann, M. M., Witt, S. H., Treutlein, J. & Brenner, H. Prospective association of dopamine-related polymorphisms with smoking cessation in general care. Pharmacogenomics 11, 527-536 (2010).
30. Gu, Z., Feng, X., Dong, X. & Chan, P. Smoking, genes encoding dopamine pathway and risk for Parkinson's disease. Neurosci. Lett. 482, 31-34 (2010).
31. Shahi, G. S. & Moochhala, S. M. Smoking and Parkinson's disease-a new perspective. Rev. Environ. Health. 9, 123-136 (1991).
32. Wirdefeldt, K., Adami, H. O., Cole, P., Trichopoulos, D. & Mandel, J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur. J. Epidemiol. 26(Suppl 1) S1-58 (2011).
33. Sato, N., Sato, T., Nozawa, A. & Sugimura, H. Assessment scales for nicotine addiction. J. Addict. Res. Ther. doi:10.4172/2155-6105.S1-008 (2012).
34. International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
35. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haplotype analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005).
36. Gabriel, S. B., Schaffner, S. F. & Nguyen, H. The structure of haplotype blocks in the human genome. Science 296, 2225-2229 (2002). (Pubitemid 34680308)